Do endogenous opioids and nitric oxide participate in the anticonvulsant action of dipyrone?

Abstract

It was previously reported that systemic administration of dipyrone inhibited the tonic component of generalized tonic-clonic seizures in both the electroshock and the audiogenic seizure models. The aim of the present study was to investigate the mechanisms involved in the anticonvulsant action of dipyrone by assessing the role of nitric oxide and opioids in the electroshock (female 60-to 90-day-old Wistar rats, N = 5-11) and audiogenic seizure (female 60-to 90-day-old Wistar audiogenic rats, N = 5-11) models of epilepsy. Naloxone (5 mg/kg, sc) significantly reversed the anticonvulsant effect of dipyrone in rats submitted to the induction of audiogenic seizures (ANOVA/Bonferroni's test), suggesting the involvement of opioid peptides in this action. In the electroshock model no reversal of the anticonvulsant effect of dipyrone by naloxone (5 mg/kg, sc) was demonstrable. The acute (120 mg/kg, ip) and chronic (25 mg/kg, ip, twice a day/4 days) administration of L-NOARG did not reverse the anticonvulsant action of dipyrone in the audiogenic seizure model, suggesting that the nitric oxide pathway does not participate in such effect. Indomethacin (10, 20 and 30 mg/kg, ip) used for comparison had no anticonvulsant effect in the audiogenic seizure model. In conclusion, opioid peptides but not nitric oxide seem to be involved in the anticonvulsant action of dipyrone in audiogenic seizures. Correspondence

Cardiac dysfunction in rats prone to audiogenic epileptic seizures

“…The most frequent behavioral sequences produce the following SI values: 0.11 = wild running with only one running fit; 0.23 = wild running with only one running fit, jumping and atonic falling; 0.38 = wild running with two running fits, jumping and atonic falling; 0.61 = all of the above plus tonic convulsion (back arching tonus); 0.73 = all the above plus partial (only forelimb or hindlimb) and generalized (forelimb and hindlimb) clonic seizures; 0.85 = all the above plus clonic spasms; 0.90 = all the above plus ventral flexion of the head; 0.95 = all the above plus forelimb hyperextension; 1.0 = all the above plus forelimb and hindlimb hyperextension. 17 In the present study only animals with SI > 0.85 (running, jumping plus clonic spasms) were included in the experimental groups.…”

Metamizole: A Review Profile of a Well-Known “Forgotten” Drug. Part I: Pharmaceutical and Nonclinical Profile

“…it has been shown that metamizole reduces the common bile duct and oddi sphincter tonus in a dose-dependent manner as well as the efferent urinary tract and urinary vesicle motility. in the last 10 years the interest in this compound has increased due to additional reported benefits, like antiapoptotic, neuroprotective, and anticonvulsant effects (68,80,82,102). there are animal studies which support the combined treatment with nSAiDs such as metamizole, with therapeutic hypothermia in order to render long-lasting neuroprotection.…”

Anticonvulsant and antiarrhythmic effects of nifedipine in rats prone to audiogenic seizures

“…A resting period of at least one week after screening was allowed before the initiation of the experimental protocols. The most frequent behavioral sequences produce the following SI values: 0.11 = wild running with only one running fit; 0.23 = wild running with only one running fit, jumping and atonic falling; 0.38 = wild running with two running fits, jumping and atonic falling; 0.61 = all of the above plus tonic convulsion (back arching tonus); 0.73 = all of the above plus partial (only forelimb or hindlimb) and generalized (forelimb and hindlimb) clonic seizures; 0.85 = all the above plus clonic spasms; 0.90 = all of the above plus ventral flexion of the head; 0.95 = all of the above plus forelimb hyperextension; 1.0 = all of the above plus forelimb and hindlimb hyperextension (14). Animals with SI >0.85 were included in the experiments.…”